To evaluate BDNF's capacity to modulate fibrin architecture under physiological conditions, rHu-BDNF was introduced into plasma aliquots from AIS/DM subjects (baseline BDNF: 7.0 ng/mL) prior to thrombin-triggered coagulation. Here, BDNF is linked to diabetes mellitus.